Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
41,086,070
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
33,260,971
-
Shares change
-
+1,150,612
-
Total reported value, excl. options
-
$188,259,076
-
Value change
-
+$6,505,885
-
Number of buys
-
34
-
Number of sells
-
-13
-
Price
-
$5.66
Significant Holders of Rallybio Corp - COMMON STOCK (RLYB) as of Q2 2023
61 filings reported holding RLYB - Rallybio Corp - COMMON STOCK as of Q2 2023.
Rallybio Corp - COMMON STOCK (RLYB) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33,260,971 shares
of 41,086,070 outstanding shares and own 81% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (4,194,777 shares), 5AM Venture Management, LLC (3,630,724 shares), New Leaf Venture Partners, L.L.C. (3,301,603 shares), FMR LLC (3,245,713 shares), TPG GP A, LLC (3,028,414 shares), Pivotal bioVenture Partners Investment Advisor LLC (2,404,644 shares), Novo Holdings A/S (2,187,999 shares), Canaan Partners XI LLC (2,059,712 shares), Tekla Capital Management LLC (1,727,067 shares), and BlackRock Inc. (1,653,859 shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.